Your browser doesn't support javascript.
loading
Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours.
Métais, Alice; Bouchoucha, Yassine; Kergrohen, Thomas; Dangouloff-Ros, Volodia; Maynadier, Xavier; Ajlil, Yassine; Carton, Matthieu; Yacoub, Wael; Saffroy, Raphael; Figarella-Branger, Dominique; Uro-Coste, Emmanuelle; Sevely, Annick; Larrieu-Ciron, Delphine; Faisant, Maxime; Machet, Marie-Christine; Wahler, Ellen; Roux, Alexandre; Benichi, Sandro; Beccaria, Kevin; Blauwblomme, Thomas; Boddaert, Nathalie; Chrétien, Fabrice; Doz, François; Dufour, Christelle; Grill, Jacques; Debily, Marie Anne; Varlet, Pascale; Tauziède-Espariat, Arnault.
Afiliación
  • Métais A; Service de Neuropathologie, GHU Psychiatrie et Neurosciences, Site Sainte-Anne, 1 Rue Cabanis, 75014, Paris, France. a.metais@ghu-paris.fr.
  • Bouchoucha Y; Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, INSERM, Université de Paris, Equipe IMA-BRAIN (Imaging Biomarkers for Brain Development and Disorders), 102-108 rue de la Santé, 75014, Paris, France. a.metais@ghu-paris.fr.
  • Kergrohen T; SIREDO Center (Care, Innovation and Research for Children, Adolescents and Young Adults), Institut Curie, Paris, France.
  • Dangouloff-Ros V; Université Paris-Cité, Paris, France.
  • Maynadier X; Team Genomics and Oncogenesis of Pediatric Brain Tumors, Molecular Predictors and New Targets in Oncology, INSERM U981, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Ajlil Y; Pediatric Radiology Department, AP-HP, Hôpital Necker Enfants Malades, Université Paris Cité, Institut Imagine INSERM U1163, 75015, Paris, France.
  • Carton M; Department of Biostatistics, Institut Curie, PSL University, Paris, France.
  • Yacoub W; Team Genomics and Oncogenesis of Pediatric Brain Tumors, Molecular Predictors and New Targets in Oncology, INSERM U981, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Saffroy R; Department of Biostatistics, Institut Curie, PSL University, Paris, France.
  • Figarella-Branger D; Pediatric Radiology Department, AP-HP, Hôpital Necker Enfants Malades, Université Paris Cité, Institut Imagine INSERM U1163, 75015, Paris, France.
  • Uro-Coste E; Department of Biochemistry and Oncogenetic, Paul-Brousse Hospital, Villejuif, France.
  • Sevely A; Aix-Marseille Univ, APHM, CNRS, INP, Inst Neurophysiopathol, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.
  • Larrieu-Ciron D; Département d'anatomie et Cytologie Pathologiques, CHU de Toulouse, IUCT-Oncopole, Toulouse, France.
  • Faisant M; Department of Radiology, Toulouse University Hospital, Toulouse, France.
  • Machet MC; Department of Neurology, Toulouse University Hospital, Toulouse, France.
  • Wahler E; Department of Medical Oncology, IUCT-Oncopole, Toulouse, France.
  • Roux A; Department of Pathology, CHU Caen, Caen, France.
  • Benichi S; Department of Pathology, CHRU Bretonneau, Tours, France.
  • Beccaria K; Service de Neuropathologie, GHU Psychiatrie et Neurosciences, Site Sainte-Anne, 1 Rue Cabanis, 75014, Paris, France.
  • Blauwblomme T; Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, INSERM, Université de Paris, Equipe IMA-BRAIN (Imaging Biomarkers for Brain Development and Disorders), 102-108 rue de la Santé, 75014, Paris, France.
  • Boddaert N; Department of Neurosurgery, GHU Paris-Psychiatrie et Neurosciences Sainte-Anne Hospital, Paris, France.
  • Chrétien F; Department of Pediatric Neurosurgery, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris-Université Paris Cité, Paris, France.
  • Doz F; Department of Pediatric Neurosurgery, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris-Université Paris Cité, Paris, France.
  • Dufour C; Department of Pediatric Neurosurgery, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris-Université Paris Cité, Paris, France.
  • Grill J; Pediatric Radiology Department, AP-HP, Hôpital Necker Enfants Malades, Université Paris Cité, Institut Imagine INSERM U1163, 75015, Paris, France.
  • Debily MA; Service de Neuropathologie, GHU Psychiatrie et Neurosciences, Site Sainte-Anne, 1 Rue Cabanis, 75014, Paris, France.
  • Varlet P; SIREDO Center (Care, Innovation and Research for Children, Adolescents and Young Adults), Institut Curie, Paris, France.
  • Tauziède-Espariat A; Université Paris-Cité, Paris, France.
Acta Neuropathol ; 145(1): 83-95, 2023 01.
Article en En | MEDLINE | ID: mdl-36264505
ABSTRACT
Pediatric spinal low-grade glioma (LGG) and glioneuronal tumours are rare, accounting for less 2.8-5.2% of pediatric LGG. New tumour types frequently found in spinal location such as diffuse leptomeningeal glioneuronal tumours (DLGNT) have been added to the World Health Organization (WHO) classification of tumours of the central nervous system since 2016, but their distinction from others gliomas and particularly from pilocytic astrocytoma (PA) are poorly defined. Most large studies on this subject were published before the era of the molecular diagnosis and did not address the differential diagnosis between PAs and DLGNTs in this peculiar location. Our study retrospectively examined a cohort of 28 children with LGGs and glioneuronal intramedullary tumours using detailed radiological, clinico-pathological and molecular analysis. 25% of spinal PAs were reclassified as DLGNTs. PA and DLGNT are nearly indistinguishable in histopathology or neuroradiology. 83% of spinal DLGNTs presented first without leptomeningeal contrast enhancement. Unsupervised t-distributed stochastic neighbor embedding (t-SNE) analysis of DNA methylation profiles showed that spinal PAs formed a unique methylation cluster distinct from reference midline and posterior fossa PAs, whereas spinal DLGNTs clustered with reference DLGNT cohort. FGFR1 alterations were found in 36% of spinal tumours and were restricted to PAs. Spinal PAs affected significantly younger patients (median age 2 years old) than DLGNTs (median age 8.2 years old). Progression-free survival was similar among the two groups. In this location, histopathology and radiology are of limited interest, but molecular data (methyloma, 1p and FGFR1 status) represent important tools differentiating these two mitogen-activated protein kinase (MAPK) altered tumour types, PA and DLGNT. Thus, these molecular alterations should systematically be explored in this type of tumour in a spinal location.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Astrocitoma / Neoplasias Encefálicas / Neoplasias del Sistema Nervioso Central / Glioma Límite: Child / Child, preschool / Humans Idioma: En Revista: Acta Neuropathol Año: 2023 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Astrocitoma / Neoplasias Encefálicas / Neoplasias del Sistema Nervioso Central / Glioma Límite: Child / Child, preschool / Humans Idioma: En Revista: Acta Neuropathol Año: 2023 Tipo del documento: Article País de afiliación: Francia
...